Repligen: 4Q Earnings Snapshot

February 21, 2019

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported fourth-quarter earnings of $5.6 million.

The Waltham, Massachusetts-based company said it had net income of 12 cents per share. Earnings, adjusted for one-time gains and costs, came to 21 cents per share.

The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of 21 cents per share.

The drug developer posted revenue of $51.9 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $50.3 million.

For the year, the company reported profit of $16.6 million, or 37 cents per share. Revenue was reported as $194 million.

Repligen expects full-year earnings in the range of 81 cents to 86 cents per share, with revenue in the range of $218 million to $225 million.

Repligen shares have risen 12 percent since the beginning of the year. The stock has risen 86 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGEN at https://www.zacks.com/ap/RGEN